Visfatin and adiponectin as early markers of atherosclerosis in type 2 diabetes mellitus
IntroductionAs cardiovascular disease is the leading cause of mortality in type 2 diabetes mellitus, new markers for early detection and risk stratification of diabetic macroangiopathy and microangiopathy are highly desired. Adipocytokines were considered to lead to an increased risk of vascular com...
Main Authors: | Ibtissam Zakaria, Mary N. Rizk, Maha Rakha, Amal Shehaby |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2013-01-01
|
Series: | The Egyptian Journal of Internal Medicine |
Subjects: | |
Online Access: | http://www.esim.eg.net/article.asp?issn=1110-7782;year=2013;volume=25;issue=3;spage=143;epage=148;aulast=Zakaria |
Similar Items
-
Association between serum visfatin levels and atherosclerotic plaque in patients with type 2 diabetes
by: Long-Yi Zheng, et al.
Published: (2019-07-01) -
Unlocking the Dietary Puzzle: How Macronutrient Intake Shapes the Relationship between Visfatin and Atherosclerosis in Type 2 Diabetes
by: Kati Kärberg, et al.
Published: (2024-03-01) -
Serum levels of adiponectin and visfatin in patients with lichen planus: a case-controlled study
by: Sahar A Ismail, et al.
Published: (2017-01-01) -
Circulating levels of adipose tissue-derived inflammatory factors in elderly diabetes patients with carotid atherosclerosis: a retrospective study
by: Wei Yang, et al.
Published: (2018-05-01) -
Chronic Administration of Visfatin Ameliorated Diabetic Nephropathy in Type 2 Diabetic Mice
by: Young Sun Kang, et al.
Published: (2016-05-01)